The median (range) PFS were 3.6 (1.0-16.3) in months for EGFR wild-type NSCLC and 4.5 (0.9-25.9) months in EGFR variant-positive NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.